HomeAPRE • NASDAQ
add
Aprea Therapeutics Inc
Previous close
$1.58
Day range
$1.54 - $1.61
Year range
$1.41 - $5.01
Market cap
8.99M USD
Avg Volume
46.23K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 118.11K | -78.97% |
Operating expense | 1.59M | -13.89% |
Net income | -3.24M | 6.66% |
Net profit margin | -2.74K | -343.78% |
Earnings per share | -0.53 | 8.62% |
EBITDA | -3.38M | 11.96% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 16.53M | -42.39% |
Total assets | 17.31M | -42.23% |
Total liabilities | 3.17M | 2.37% |
Total equity | 14.14M | — |
Shares outstanding | 5.83M | — |
Price to book | 0.68 | — |
Return on assets | -45.13% | — |
Return on capital | -54.64% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -3.24M | 6.66% |
Cash from operations | -3.13M | 14.03% |
Cash from investing | — | — |
Cash from financing | 384.88K | 1,927.54% |
Net change in cash | -2.74M | 25.35% |
Free cash flow | -2.04M | 12.88% |
About
Website
Employees
8
